ABSTRACT Catheter balloon inflation performed during percutaneous transluminal coronary angioplasty (PTCA) results in temporary interruption of coronary blood flow and subsequent myocardial ischemia. This produces transient but profound regional left ventricular dysfunction. In an effort to mitigate this inflation-related dysfunction, oxygenated Fluosol DA 20%, a perfluorochemical oxygen transport fluid, was infused distal to the balloon through the central lumen of the dilating catheter during balloon inflation. Regional wall motion during PTCA was assessed by simultaneous continuous two-dimensional echocardiography and was quantified by computer analysis. During control inflations accompanied by no intracoronary infusion or by transcatheter infusion of Ringer's lactate solution or nonoxygenated Fluosol DA 20%, there was profound regional left ventricular dysfunction with a greater than 90% decrease in regional contraction. In contrast, regional contraction during transcatheter infusion of oxygenated Fluosol DA 20% remained at normal levels throughout balloon inflation. Distal infusion of Fluosol DA 20% during balloon inflation is a useful adjunct to PTCA, allowing longer inflation times and perhaps permitting PTCA to be performed safely in patients with significant myocardium at ischemic risk or with limited left ventricular reserve for whom the procedure is currently believed to be too hazardous. Circulation 74, No. 3, 555-562, 1986. PERCUTANEOUS transluminal coronary angioplasty (PTCA) is a procedure that has gained wide acceptance. However, balloon inflation during this procedure results in transient interruption of coronary artery blood flow and subsequent regional ischemia. Using two-dimensional echocardiography, we have demonstrated reproducible transient regional left ventricular wall motion abnormalities during balloon inflation in patients undergoing PTCA. 1,2 Prevention of regional mechanical abnormalities incurred during balloon inflation may allow prolongation of the inflation period and expansion of the patient population currently deemed eligible for PTCA. Recent evidence suggests that prolonged inflation times result in superior primary success rates and lower residual gradients and angiographic stenoses.3 4 In addition, a subset of patients with large regions of myocardium at risk or limited contractile reserve caused by prior inflation are cur- rently at high risk for hemodynamic instability as a result of profound contractile dysfunction during balloon inflation. Efforts to mitigate regional ischemia during balloon inflation have involved intracoronary infusion of whole blood distal to the dilatation balloon.5 The viscosity characteristics of whole blood make its delivery via the distal lumen of the dilating catheter difficult and its infusion at high flow rates may potentially result in significant hemolysis. Fluosol DA 20% is a perfluorochemical emulsion that can deliver oxygen effectively to ischemic tissue at adequate flow rates and has been used as a blood substitute. Therefore we tested the hypothesis that delivery of adequate oxygen to obstructed coronary beds with oxygenated Fluosol DA 20% can prevent the profound regional left ventricular wall motion abnormalities that result from balloon inflation during PTCA. We further evaluated the importance of metabolite accumulation in the production of acute ischemic regional contractile dysfunction by examining the effect of byproduct 'washout" with either oxygenated Ringer's lactate or nonoxygenated Fluosol DA 20%. 
PERCUTANEOUS transluminal coronary angioplasty (PTCA) is a procedure that has gained wide acceptance. However, balloon inflation during this procedure results in transient interruption of coronary artery blood flow and subsequent regional ischemia. Using two-dimensional echocardiography, we have demonstrated reproducible transient regional left ventricular wall motion abnormalities during balloon inflation in patients undergoing PTCA. 1,2 Prevention of regional mechanical abnormalities incurred during balloon inflation may allow prolongation of the inflation period and expansion of the patient population currently deemed eligible for PTCA. Recent evidence suggests that prolonged inflation times result in superior primary success rates and lower residual gradients and angiographic stenoses.3 4 In addition, a subset of patients with large regions of myocardium at risk or limited contractile reserve caused by prior inflation are cur-rently at high risk for hemodynamic instability as a result of profound contractile dysfunction during balloon inflation.
Efforts to mitigate regional ischemia during balloon inflation have involved intracoronary infusion of whole blood distal to the dilatation balloon.5 The viscosity characteristics of whole blood make its delivery via the distal lumen of the dilating catheter difficult and its infusion at high flow rates may potentially result in significant hemolysis. Fluosol DA 20% is a perfluorochemical emulsion that can deliver oxygen effectively to ischemic tissue at adequate flow rates and has been used as a blood substitute. Therefore we tested the hypothesis that delivery of adequate oxygen to obstructed coronary beds with oxygenated Fluosol DA 20% can prevent the profound regional left ventricular wall motion abnormalities that result from balloon inflation during PTCA. We further evaluated the importance of metabolite accumulation in the production of acute ischemic regional contractile dysfunction by examining the effect of byproduct ' Centerline E Inferior FIGURE lB. End-diastolic (ED) and end-systolic (ES) endocardial boundaries are drawn from the two-dimensional echocardiographic apical long-axis view and computer digitized by operator control. The computer calculates a centerline between the two boundaries and constructs 100 equally spaced chords perpendicular to that line (see figure   2 , A).
CIRCULATION
The validity of the centerline technique for quantitating regional wall motion by two-dimensional echocardiography was established by the application of the technique to a cohort of eight patients with normal global and regional wall motion and eight patients with chronic anterior wall myocardial infarction who had undergone both contrast ventriculography and twodimensional echocardiography. Analysis of regional chord shortening revealed a correlation coefficient of .74 with clear separation of the normal group from the group with anterior wall infarction (p < .01). Chronic anterior wall infarcts were chosen because of the analogy they provided to the regional wall motion abnormalities expected during PTCA of proximal left anterior descending coronary arteries.
Three types of variability in regional wall motion measurement with this technique were evaluated. To determine intraobserver variability, 15 end-diastolic frames and 15 end-systolic frames taken from apical long-axis recordings from five patients with coronary artery disease were traced by the same operator, with at least 2 days between tracings. Intraobserver variability in quantification of mean chord shortening of 10 chord groups in the septal and apical areas was 7 + 4% and 10 + 7% of mean motion, respectively.
To determine interobserver variability, the same 15 end-diastolic and 15 end-systolic frames were traced by different operators. Interobserver variability was 12 + 6% in the septal region and 14 + 7% in the apex. Beat-to-beat variability was determined in five patients with coronary artery disease continuously imaged by two-dimensional echocardiography for 3 min in a baseline resting state. Quantification of regional wall motion was performed by the same operator (on the same day) on 10 beats, each separated by 10 Hemodynamics. Baseline measurements of mean, systolic, and diastolic pulmonary arterial pressure were 17 ± 5, 26 ± 7, and 12 ± 5 mm Hg, respectively. Baseline pulmonary capillary wedge pressures were 10 ± 4 mm Hg, heart rate was 72 ± 17 beats/ min, and arterial blood pressure was 127 ± 20/72 ± 13 mm Hg. Heart rate and arterial blood pressure were unchanged (p < .10, p = NS) after intracoronary infusions. Pulmonary capillary wedge pressure increased to 16 ± 5 mm Hg (p < .01) and mean, systolic, and diastolic pulmonary arterial pressures rose to 24 ± 7, 35 + 12, and 17 ± 6 mm Hg, respectively (p < .01), after the final balloon inflation of the sequence.
Discussion
This study demonstrates that oxygenated Fluosol DA 20% (Po2 greater than 600 mm Hg) infused through the distal lumen of the dilating balloon catheter at 60 ml/min during balloon inflation prevents the regional dysfunction incurred during control balloon inflation without infusion. Administration of Fluosol DA 20% in total doses of less than 400 ml was safe and well tolerated in this patient population. Alternative explanations for regional contractile protection during multiple balloon inflations may center on the findings from prior studies that have demonstrated the dynamic nature of collaterals during coronary angioplasty. In our study, the presence of collaterals was evaluated angiographically before PTCA but was not evaluated during balloon inflation. Prior studies in our institution have demonstrated no change in the magnitude of regional dysfunction or temporal pattern between first and last balloon inflation sequences. Thus collaterals, if present, appear to have little influence on regional mechanical events. The temporal sequence of regional dysfunction and the magnitude of this dysfunction are again reproducible in the balloon inflation sequences without infusion in this study. Long-term use of medications was variable but would not be expected to influence the results of this study, since patients served as their own controls in a multi-inflation sequence.
Fluosol DA 20% has several favorable characteristics that are potentially responsible for its beneficial effects in preserving regional cardiac contraction during PICA:
(1) The perfluorocarbon emulsion has a linear oxygen dissociation curve, allowing it to deliver oxygen effectively to ischemic tissllw<. When oxygenated to a Po2 of greater than 600 mm rig it has the capacity to deliver approximately 5.0 vol % of oxygen to ischemic tissue. This figure is similar to that found with whole blood at a hematocrit of 43%. Ringer's lactate solution, on the other hand, when oxygenated by the same method is capable of delivering less than 2 vol % of oxygen.
(2) Fluosol DA 20% has a CO2 affinity comparable to that of whole blood, allowing it to efficiently remove CO2 from ischemic regions. 22 (3) The viscosity of Fluosol DA 20% is approximately 50% that of whole blood at body temperature. This feature, combined with its particle size of 0.1 to 0.2 2,um ( ly and hemodynamically by left ventricular end-diastolic pressure and dP/dt.
We have noted that cessation of intracoronary ad-;ninistration of Fluosol DA 20% at the end of balloon Lnflation results in an abrupt transient fall in regional ±hord shortening (p < .01) despite concomitant balLoon deflation. Possible explanations for this observaion include the following: (1) Abrupt closure of capilary beds opened by the perfluorocarbon emulsion may iave occurred after discontinuation of Fluosol DA 20%; (2)°2 delivery durl.g administration of Fluosol DA 20% may have been more effective during infusion :han blood reperfusion due to improvement in the°2 iffinity characteristic of the blood-fluorocarbon mixLure in ischemic tissue22; (3) improved delivery of oxygen to ischemic border zones may have occurred be-:ause of the minute particle size and improved liffusion.
In summary, balloon inflation during PTCA results Ln transient but profound regional wall motion abnormalities that can be prevented by delivery of oxygenated Fluosol DA 20% through the distal lumen of the dilating catheter. Administration of oxygenated Fluosol DA 20% may be an important adjunct during coronary angioplasty, allowing more widespread utilization of the procedure and improved primary and long-term success.
